{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:04:37Z","timestamp":1772478277069,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"New York Blood Center"},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic and local, regional and national public health policies to limit coronavirus spread as well as \u201creopen\u201d cities and states, are best informed by serum neutralizing antibody titers measured by reproducible, high throughput, and statically credible antibody (Ab) assays. To date, a myriad of Ab tests, both available and FDA authorized for emergency, has led to confusion rather than insight per se. The present study reports the results of a rapid, point-in-time 1,000-person cohort study using serial blood donors in the New York City metropolitan area (NYC) using multiple serological tests, including enzyme-linked immunosorbent assays (ELISAs) and high throughput serological assays (HTSAs). These were then tested and associated with assays for neutralizing Ab (NAb). Of the 1,000 NYC blood donor samples in late June and early July 2020, 12.1% and 10.9% were seropositive using the Ortho Total Ig and the Abbott IgG HTSA assays, respectively. These serological assays correlated with neutralization activity specific to SARS-CoV-2. The data reported herein suggest that seroconversion in this population occurred in approximately 1 in 8 blood donors from the beginning of the pandemic in NYC (considered March 1, 2020). These findings deviate with an earlier seroprevalence study in NYC showing 13.7% positivity. Collectively however, these data demonstrate that a low number of individuals have serologic evidence of infection during this \u201cfirst wave\u201d and suggest that the notion of \u201cherd immunity\u201d at rates of ~60% or higher are not near. Furthermore, the data presented herein show that the nature of the Ab-based immunity is not invariably associated with the development of NAb. While the blood donor population may not mimic precisely the NYC population as a whole, rapid assessment of seroprevalence in this cohort and serial reassessment could aid public health decision making.<\/jats:p>","DOI":"10.1371\/journal.pone.0250319","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T16:25:40Z","timestamp":1619627140000},"page":"e0250319","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and \u201cReopening\u201d"],"prefix":"10.1371","volume":"16","author":[{"given":"Daniel K.","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidee","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianna","family":"Vandergaast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Kyratsous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Baras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Hillyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-1764","authenticated-orcid":true,"given":"Larry L.","family":"Luchsinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"4","key":"pone.0250319.ref001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"KG Andersen","year":"2020","journal-title":"Nat Med"},{"issue":"7798","key":"pone.0250319.ref002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"F Wu","year":"2020","journal-title":"Nature"},{"issue":"5","key":"pone.0250319.ref003","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1473-3099(20)30144-4","article-title":"Early dynamics of transmission and control of COVID-19: a mathematical modelling study","volume":"20","author":"AJ Kucharski","year":"2020","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"pone.0250319.ref004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcv.2009.02.011","article-title":"Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus","volume":"45","author":"CM Chan","year":"2009","journal-title":"J Clin Virol"},{"key":"pone.0250319.ref005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fimmu.2020.00879","article-title":"Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control","volume":"11","author":"CY Lee","year":"2020","journal-title":"Front Immunol."},{"key":"pone.0250319.ref006","article-title":"Serological Analysis of New York City COVID19 Convalescent Plasma Donors","author":"LL Luchsinger","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"pone.0250319.ref007","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13104-020-05212-0","article-title":"COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors.","volume":"13","author":"B Ragnesola","year":"2020","journal-title":"BMC Res Notes."},{"issue":"6","key":"pone.0250319.ref008","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/JVI.79.6.3401-3408.2005","article-title":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein","volume":"79","author":"X Zhong","year":"2005","journal-title":"J Virol"},{"key":"pone.0250319.ref009","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"W Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"pone.0250319.ref010","first-page":"1","article-title":"Efficacy of Serology Testing in Predicting Reinfection in Patients with SARS-CoV-2","volume":"2020","author":"R Chaturvedi","journal-title":"Disaster Med Public Health Prep"},{"key":"pone.0250319.ref011","first-page":"CD013652","article-title":"Antibody tests for identification of current and past infection with SARS-CoV-2","volume":"6","author":"JJ Deeks","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0250319.ref012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annepidem.2020.06.004","article-title":"Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York","volume":"48","author":"ES Rosenberg","year":"2020","journal-title":"Ann Epidemiol."},{"issue":"46","key":"pone.0250319.ref013","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.15585\/mmwr.mm6946a2","article-title":"COVID-19 Outbreak\u2014New York City, February 29-June 1, 2020","volume":"69","author":"CN Thompson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0250319.ref014","article-title":"Correcting under-reported COVID-19 case numbers","author":"A. Lachmann","year":"2020","journal-title":"medRxiv."},{"key":"pone.0250319.ref015","volume-title":"2010 Census of Population and Housing on Summary Population and Housing Characteristics","author":"USCensusBureau","year":"2013"},{"key":"pone.0250319.ref016","article-title":"SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region","author":"DA Martinez","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"pone.0250319.ref017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0b013e32833e5ac7","article-title":"Minority donation in the United States: challenges and needs","volume":"17","author":"BH Shaz","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"pone.0250319.ref018","doi-asserted-by":"crossref","first-page":"100404","DOI":"10.1016\/j.eclinm.2020.100404","article-title":"The impact of ethnicity on clinical outcomes in COVID-19: A systematic review","volume":"23","author":"D Pan","year":"2020","journal-title":"EClinicalMedicine."},{"issue":"7844","key":"pone.0250319.ref019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2912-6","article-title":"Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","volume":"590","author":"D Stadlbauer","year":"2021","journal-title":"Nature"},{"issue":"16","key":"pone.0250319.ref020","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"KS Corbett","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0250319.ref021","article-title":"A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates","author":"AB Vogel","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0250319.ref022","article-title":"Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients","author":"LL Luchsinger","year":"2020","journal-title":"J Clin Microbiol"},{"key":"pone.0250319.ref023","article-title":"Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19","author":"MJ Joyner","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0250319.ref024","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jamainternmed.2020.4616","article-title":"Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China","volume":"180","author":"F Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"pone.0250319.ref025","unstructured":"BERGEN COUNTY MOBILE TESTING STATISTICS AND WEEK 9 LOCATIONS [press release]. online, July 2, 2020 2020."},{"issue":"9","key":"pone.0250319.ref026","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2020.14765","article-title":"Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area","volume":"324","author":"J Moscola","year":"2020","journal-title":"JAMA"},{"key":"pone.0250319.ref027","article-title":"1.5 Million Antibody Tests Show What Parts of N.Y.C. Were Hit Hardest","author":"J. Goldstein","year":"2020","journal-title":"The New York Times"},{"key":"pone.0250319.ref028","article-title":"Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats","author":"DJ Nesbitt","year":"2020","journal-title":"medRxiv"},{"key":"pone.0250319.ref029","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","author":"J Seow","year":"2020","journal-title":"Nat Microbiol"},{"key":"pone.0250319.ref030","article-title":"Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2","author":"R Vandergaast","year":"2020","journal-title":"bioRxiv"},{"issue":"2","key":"pone.0250319.ref031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval Estimation for a Binomial Proportion","volume":"16","author":"LD Brown","year":"2001","journal-title":"Statist Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T16:26:20Z","timestamp":1619627180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250319"}},"subtitle":[],"editor":[{"given":"Nicholas J.","family":"Mantis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0250319","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.06.20220087","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}